Recently Featured

Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna’s mNexspike

April 25, 2026
Sanofi’s protein-based vaccine Nuvaxovid has demonstrated superior tolerability compared to Moderna’s next-generation messenger RNA vaccine, mNexspike, in a recent head-to-head trial. This finding is significant as it highlights the ongoing competition between traditional protein-based vaccines and newer mRNA technologies in the COVID-19 vaccine landscape. The context of this trial is critical, given the increasing scrutiny…

UCB to purchase Neurona and NRTX-1001 for $1.15bn

April 25, 2026
UCB has signed a definitive agreement to acquire Neurona Therapeutics in a deal valued at up to $1.15 billion, significantly enhancing its epilepsy portfolio with the addition of Neurona’s lead asset, NRTX-1001. This acquisition underscores UCB’s strategic focus on expanding its neurology pipeline, particularly in addressing unmet needs in epilepsy management. The integration of NRTX-1001,…

Genentech shifts Hemlibra marketing focus to patient stories as competition approaches

April 25, 2026
Genentech has launched the “Life Doesn’t Wait” campaign to coincide with World Hemophilia Day, emphasizing patient narratives as it prepares for increased competition in the hemophilia A market. This strategic pivot reflects a growing recognition of the importance of personalized marketing in the pharmaceutical industry, particularly as competitors gear up to challenge Hemlibra’s market share.…

Digital Twins Become the New Battleground for CDMOs

April 25, 2026
Contract Development and Manufacturing Organizations (CDMOs) are increasingly leveraging digital twin technology to gain a competitive edge in the pharmaceutical manufacturing landscape. This innovative approach allows CDMOs to create virtual replicas of physical processes, enabling real-time monitoring and optimization of production workflows. The integration of digital twins into manufacturing processes not only enhances operational efficiency…

Ongoing Cases